Sensitive GATA1 mutation screening reliably identifies neonates with Down syndrome at risk for myeloid leukemia.
Bianca F GoemansSanne NoortMarjolein BlinkYong-Dong WangSusan T C J PetersJacobus P van WouweGertjan KaspersValerie de HaasWouter J KollenVincent H J van der VeldenTanja A GruberChristian M ZwaanPublished in: Leukemia (2021)